People
We are a highly-experienced team of drug discovery and development experts focused on making therapies happen that will change the way we age.
christian angermayer
co-founder & chairman of the board
shannon klinger
member of the board of directors
teresa deluca
md, mba
member of the board of directors
aaron weaver
cfa
member of the board of directors
gregory weaver
mba
member of the board of directors
aksana labokha
phd
chief executive officer
caleb morgret
cfa
chief financial officer
karim allam
mba, llm, ccp
chief legal & people officer
matthias steger
phd mba
co-founder
patrick schnider
phd
vp medicinal chemistry - rejuveron telomere therapeutics
prof. manuel serrano
phd
co-founder & scientific advisor - rejuveron senescence therapeutics
timothy cash
phd
co-founder & chief scientific officer - rejuveron senescence therapeutics
tristan heintz
phd
chief scientific officer - rejuveron vascular therapeutics
chien chi hsiao
phd
head of medicinal chemistry - rejuveron telomere therapeutics
marianna feretzaki
phd
chief executive officer a.i. - rejuveron telomere therapeutics
pierre-antoine mudry
bba ms
head, corporate finance and investor relations
kara chatelin
head of finance
daniele lionetti
msc
finance associate
naffi wade
director compliance & strategic projects
lisa caflisch
lab operations manager & bso
csaba budai
it operations manager
malaika schroeder
ma
director marketing & communications
dovaine picazo
executive assistant
prof. hideyuki okano
md phd
member of the scientific advisory board
prof. lee rubin
phd
co-founder - rejuveron vascular therapeutics